Alnylam nabs key additional indication for Amvuttra
by
Contributor since / Followers
Contributor since / Followers
4 days ago
Md Saiful Islam Khan The U.S. FDA on Thursday approved Alnylam Pharmaceuticals’ (NASDAQ:ALNY) application to
PFE
U.S. boosts bird flu response with another $100M in funds
by
Contributor since / Followers
Contributor since / Followers
4 days ago
MicroStockHub The U.S. Department of Agriculture (USDA) on Thursday announced plans to spend up to
Pfizer exits Haleon stake after $3.2B share sale
by
Contributor since / Followers
Contributor since / Followers
5 days ago
JHVEPhoto/iStock Editorial via Getty Images Pfizer (NYSE:PFE) has generated ??2.5B ($3.24B) after selling its entire
Pfizer to sell remaining stake in Haleon
by
Contributor since / Followers
Contributor since / Followers
6 days ago
JHVEPhoto/iStock Editorial via Getty Images Pfizer (NYSE:PFE) is planning to sell 662M shares of Haleon
Zai Lab gets China review for Pfizer-partnered cervical cancer therapy
by
Contributor since / Followers
Contributor since / Followers
2 weeks ago
koto_feja Zai Lab Limited (NASDAQ:ZLAB) announced Thursday that Chinese regulators accepted its marketing application for
Arvinas draws Wedbush downgrade after data for Pfizer-partnered cancer drug
by
Contributor since / Followers
Contributor since / Followers
2 weeks ago
mbbirdy Wedbush became the latest brokerage to downgrade Arvinas (NASDAQ:ARVN) on Wednesday after the company
ViiV releases promising phase 2 data on potential long-acting HIV drugs
by
Contributor since / Followers
Contributor since / Followers
2 weeks ago
Gam1983 ViiV Healthcare, which is majority owned by GSK (NYSE:GSK), said that two HIV antiretroviral
Pfizer, Arvinas post mixed late-stage trial results for breast cancer therapy
by
Contributor since / Followers
Contributor since / Followers
2 weeks ago
Nemes Laszlo/iStock via Getty Images Pfizer (NYSE:PFE) and its partner Arvinas (NASDAQ:ARVN) for the experimental
CDC plans to study possible link between vaccines and autism – report
by
Contributor since / Followers
Contributor since / Followers
2 weeks ago
The CDC is planning to conduct a large study to investigate potential links between vaccines
Pfizer boosts anti-obesity efforts: names former J&J exec. as chief internal medicine officer
by
Contributor since / Followers
Contributor since / Followers
2 weeks ago
Jeenah Moon/Getty Images News Pfizer (NYSE:PFE) has named James List, a former Johnson & Johnson